Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 714-717

  Zhao, Hua ^a   Grossman, H Barton ^a   Spitz, Margaret R ^a   Lerner, Seth P ^a   Zhang, Kerang ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bladder; Bladder neoplasms; Insulin like growth factor binding protein 3; Insulin like growth factor 1; Risk

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLADDER CANCER; BLADDER DISEASE; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PLASMA; PRIORITY JOURNAL; URINARY TRACT CANCER;

EID: 0037306672     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)63999-7     Document Type: Article

References (20)

1. Aaronson, S. A.: Growth factors and cancer. Science, 254: 1146, 1991
2. LeRoith, D., Werner, H., Beitner-Johnson, D. and Roberts, C. T., Jr.: Molecular and cellular aspects of insulin-like growth factor I receptor. Endocr Rev, 16: 143, 1995
3. Dunn, S. E., Hardman, R. A., Kari, F. W. and Barrett, J. C.: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res, 57: 2687, 1997
4. Cohen, L. A., Choi, K. W. and Wang, C. X.: Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res, 48: 4276, 1988
5. Wu, X., Yu, H., Amos, C. I., Hong, W. K, and Spitz, M. R.: Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst, 92: 737, 2000
6. Nickerson, T., Huynh, H. and Pollack, M.: Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun, 237: 690, 1997
7. De Mellow, J. S. and Baxter, R. C.: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun, 156: 199, 1988
8. Hursting, S. D., Perkins, S. N., Phang, J. M. and Barrett, J. C.: Diet and cancer prevention studies in p53-deficient mice. J Nutr, suppl., 131: 3092s, 2001
9. Sun, H. Z., Wu, S. F. and Tu, Z. H.: Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity. Cell Res, 11: 107, 2001
10. Chokkalingam, A. P., Pollack, M., Fillmore, C. M., Gao, Y. T., Stanczyk, F. Z., Deng, J. et al: Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev, 10: 421, 2001
11. Shariat, S. F., Lamb, D. J., Kattan, M. W., Nguyen, C., Kim, J., Beck, J. et al: Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J Clin Oncol, 20: 833, 2002
12. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B. et al: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393, 1998
13. Giovannucci, E., Pollak, M. N., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N. et al: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev, 9: 345, 2000
14. Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K. and Wu, X.: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst, 91: 151, 1999
15. Breslow, N. E. and Day, N. E.: Statistical methods in cancer research. Volume I - the analysis of case-control studies. IARC Sci Publ, 32: 5, 1980
16. Jones, J. I. and Clemmons, D. R.: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev, 16: 3, 1995
17. You, H., Zheng, M., Murray, S. A., Yu, Q., Uchida, T., Fan, D. et al: IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J Cell Biochem, 84: 211, 2002
18. Ma, J., Pollack, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H. et al: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst, 91: 620, 1999
19. Vadgama, J. V., Wu, Y., Datta, G., Khan, H. and Chillar, R.: Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probablity of survival in African-American and Hispanic women. Oncology, 57: 330, 1999
20. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A. and Henderson, B. E.: Increased cell division as a cause of human cancer. Cancer Res, 50: 7415, 1990